Imatinib mesylate

• Post Date:

  Oct 20,2021

• Expiry Date:

  Oct 20,2022

• Detailed Description:

  Cas No. :220127-57-1 No.： CPTA003
  Products： Imatinib mesylate
  Synonyms： N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-(4-methylpiperazin-1-yl)benzamide methanesulfonate
  Cas No.： 220127-57-1
  Molecular Formula： C30H35N7O4S
  Molecular Weight： 589.71
  Assay： ＞99.7%
  Usage： Used in the treatment of chronic myelogenous leukemia (CML) rapidly varied period, acceleration peri
  Molecular Structure：
  Imatinib mesylate in May at the cellular level in vivo and in vitro inhibition of Bcr - Abl tyrosine kinase, can selectively inhibit Bcr - Abl, Ph chromosome positive positive cell line cells of chronic myeloid leukemia and acute lymphoblastic leukemia patient fresh cell proliferation and induce its apoptosis. Moreover, imatinib mesylate can inhibit platelet derivation growth factor (PDGF) receptors, stem cell factor (SCF), c - Kit receptor tyrosine kinase, thus inhibiting by PDGF and stem cell factor mediating cell behavior.
  

• CAS Registry Number:

  220127-57-1

• Synonyms:

  ;Glivec;gleevec;imatinib methanesulfonate;imatinib mesilate;4-[(4-methylpiperazin-1-yl)methyl]-n-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide methanesulfonate;4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide monomethanesulfonate;Imatinibmesylate;Imatinib mesylate(Alpha form);

• Molecular Formula:

  C₃₀H₃₅N₇O₄S

• Molecular Weight:

  589.71

• Molecular Structure:

  

• Company:

  Tianjin Chempharmatech Co.,Ltd.     [ China ]        

• Contact:

  Emy

• Tel:

  +86-022-66211079

• Fax:

  +86-022-66211179

• Email:

  wuzhanyuan@chempharmatech.com